Lv2
114 积分 2024-01-21 加入
Kv1.3 in the spotlight for treating immune diseases
1小时前
已完结
Emerging small molecules for ulcerative colitis: clinical advancements and trial insights
27天前
已完结
Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: A comparative study using anti-TNFα, anti-IL-1α/β and IL-1Ra
28天前
已完结
Generation and functional evaluation of bispecific T cell engaging antibodies
1个月前
已完结
Abstract 4410: The discovery and development of a bispecific T cell engager prodrug targeting ENPP3
1个月前
已关闭
Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease
1个月前
已完结
First step towards predicting clinical immunogenicity of biologics using in vitro based readouts as animal trial alternatives
1个月前
已完结
Discovery of a gut-restricted LANCL2 agonist for the treatment of inflammatory bowel disease
1个月前
已完结
Species differences influencing the safety assessment of CD3 T-cell engagers
1个月前
已完结
Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation
1个月前
已完结
皖公网安备34019202002308
